V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20163422 | 20062979 | 1.98 | 66.7 | Adjuvant (A) | 2019-05-20 | 2019-05-20 | Gemcitabine + Capecitabine | N | N | CAPECITABINE + GEMCITABINE | 101469769 |
| 20163427 | 20062980 | 1.7 | 76.2 | Adjuvant (A) | null | 2018-03-09 | CAPECITABINE + GEMCITABINE | N | N | CAPECITABINE + GEMCITABINE | 101823352 |
| 20163428 | 20062981 | 1.65 | 78.8 | Palliative (P) | 2018-09-29 | 2018-10-06 | Gemcitabine + Capecitabine | 02 | Y | CAPECITABINE + GEMCITABINE | 101766434 |
| 20163431 | 20062982 | 1.77 | 78.7 | Palliative (P) | 2016-10-23 | 2016-10-28 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100718011 |
| 20163433 | 20062983 | 1.79 | 109.3 | Adjuvant (A) | 2018-12-09 | 2019-01-02 | Gemcitabine + Capecitabine | 02 | null | CAPECITABINE + GEMCITABINE | 101225475 |
| 20163439 | 20062984 | 1.56 | 71.8 | Palliative (P) | 2019-03-14 | 2019-03-28 | ECX | N | N | ECX | 100910078 |
| 20163442 | 20062985 | 1.72 | 82.4 | Adjuvant (A) | null | 2019-09-03 | Gemcitabine + Capecitabine | 02 | Y | CAPECITABINE + GEMCITABINE | 100794651 |
| 20163450 | 20062986 | 1.8 | 59.4 | Neo-adjuvant (N) | 2017-02-19 | 2017-02-19 | ECX | 02 | N | ECX | 101604014 |
| 20163455 | 20062987 | 158.5 | 78.6 | Neo-adjuvant (N) | 2016-02-23 | 2016-02-23 | CAPECITABINE + GEMCITABINE | 2 | N | CAPECITABINE + GEMCITABINE | 100240822 |
| 20163468 | 20062988 | 1.54 | 55.65 | Neo-adjuvant (N) | 2019-08-29 | 2019-08-29 | Gemcitabine + Capecitabine | N | N | ECX | 101136097 |
| 20163469 | 20062989 | 1.45 | 83.55 | Adjuvant (A) | 2017-10-31 | 2018-03-16 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101574002 |
| 20163471 | 20062990 | 1.53 | 49.5 | Neo-adjuvant (N) | 2018-01-09 | 2018-01-29 | ECX | N | N | ECX | 100616457 |
| 20163473 | 20062991 | 1.7 | 102.8 | Palliative (P) | 2019-06-08 | 2019-07-12 | ECX | 02 | N | ECX | 101005479 |
| 20163482 | 20062992 | 1.61 | 75.8 | Neo-adjuvant (N) | 2016-12-13 | 2016-12-20 | ECX | 2 | N | ECX | 100729493 |
| 20163484 | 20062993 | 1.68 | 68 | Neo-adjuvant (N) | 2018-02-17 | 2018-02-20 | Gemcitabine + Capecitabine | 02 | N | ECX | 100557665 |
| 20163488 | 20062994 | 1.71 | 59.6 | Adjuvant (A) | 2017-04-01 | 2017-04-05 | ECX | 02 | N | ECX | 101648294 |
| 20163489 | 20062995 | 1.66 | 58.5 | Neo-adjuvant (N) | 2017-06-21 | 2017-07-18 | ECX | N | N | ECX | 101566286 |
| 20163496 | 20062996 | 1.56 | 68.35 | Neo-adjuvant (N) | 2020-01-12 | 2020-01-12 | ECX | 02 | N | ECX | 100291565 |
| 20163500 | 20062997 | 1.63 | 75.5 | Adjuvant (A) | 2018-01-23 | 2018-01-23 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100074790 |
| 20163503 | 20062998 | 1.8 | 61.3 | Palliative (P) | null | 2017-05-28 | CAPECITABINE + GEMCITABINE | N | N | CAPECITABINE + GEMCITABINE | 100066433 |
| 20163504 | 20062999 | 1.72 | 101 | Neo-adjuvant (N) | 2017-06-03 | 2017-06-03 | ECX | 02 | N | ECX | 100507294 |
| 20163506 | 20063000 | 1.59 | 94.5 | Neo-adjuvant (N) | 2018-04-29 | 2018-05-09 | Gemcitabine + Capecitabine | N | N | CAPECITABINE + GEMCITABINE | 100754065 |
| 20163515 | 20063001 | 1.55 | 77.6 | Palliative (P) | 2019-01-18 | 2019-01-19 | CAPECITABINE + GEMCITABINE | 02 | null | CAPECITABINE + GEMCITABINE | 101516072 |
| 20163522 | 20063002 | 1.87 | 96 | Neo-adjuvant (N) | 2018-12-01 | 2018-12-04 | ECX | N | N | ECX | 101662080 |
| 20163528 | 20063003 | 1.68 | 77 | Neo-adjuvant (N) | 2019-11-11 | 2019-11-23 | ECX | N | N | ECX | 101661524 |
| 20163531 | 20063004 | 1.7 | 81 | null | 2017-01-26 | 2017-02-08 | CAPECITABINE + GEMCITABINE | 02 | Y | CAPECITABINE + GEMCITABINE | 101362697 |
| 20163537 | 20063005 | 1.63 | 66 | Palliative (P) | 2019-04-21 | 2019-04-24 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 100339020 |
| 20163540 | 20063006 | 1.68 | 102.8 | Neo-adjuvant (N) | 2016-06-02 | 2016-06-16 | ECX | 2 | N | ECX | 101503193 |
| 20163542 | 20063007 | 1.66 | 74.4 | Adjuvant (A) | 2019-06-30 | 2019-07-03 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101487555 |
| 20163552 | 20063008 | 1.71 | 91 | Palliative (P) | 2017-03-08 | 2017-03-14 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 101736008 |
| 20163555 | 20063009 | 1.84 | 80.95 | null | 2019-07-24 | 2019-08-06 | ECX | N | N | ECX | 100739202 |
| 20163558 | 20063010 | 1.7 | null | Palliative (P) | 2018-04-04 | 2018-04-09 | ECX | N | N | ECX | 100619544 |
| 20163563 | 20063011 | null | 60.8 | Adjuvant (A) | 2017-01-07 | 2017-02-18 | Gemcitabine + Capecitabine | 02 | null | CAPECITABINE + GEMCITABINE | 101297554 |
| 20163569 | 20063012 | 1.8 | 78.1 | null | 2018-12-02 | 2018-12-14 | ECX | N | N | CAPECITABINE + GEMCITABINE | 101203705 |
| 20163570 | 20063013 | 1.67 | 93.4 | Palliative (P) | 2017-11-05 | 2017-11-13 | Gemcitabine + Capecitabine | 2 | N | CAPECITABINE + GEMCITABINE | 100372100 |
| 20163574 | 20063014 | 1.5 | 64.35 | Adjuvant (A) | 2019-03-22 | 2019-03-27 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 100625324 |
| 20163579 | 20063015 | 1.62 | 62 | Neo-adjuvant (N) | 2016-12-22 | 2017-01-05 | ECX | N | N | ECX | 100654253 |
| 20163580 | 20063016 | 1.84 | 60.6 | Neo-adjuvant (N) | 2018-11-27 | 2018-12-11 | ECX | N | N | ECX | 100233114 |
| 20163581 | 20063017 | 1.8 | 88.2 | Curative (C) | 2016-07-21 | 2016-07-30 | ECX | N | N | ECX | 101844300 |
| 20163583 | 20063018 | 1.66 | 53.6 | Palliative (P) | 2016-10-15 | 2016-10-26 | ECX | 02 | N | ECX | 101649505 |
| 20163584 | 20063019 | 1.64 | 56.8 | Neo-adjuvant (N) | 2019-06-12 | 2019-06-29 | ECX | N | N | ECX | 101404834 |
| 20163587 | 20063020 | 1.8 | 45.1 | Neo-adjuvant (N) | 2016-06-09 | 2016-06-15 | ECX | 02 | N | ECX | 101273312 |
| 20163595 | 20063021 | 1.77 | 64.6 | Palliative (P) | 2016-04-19 | 2016-04-21 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 101462283 |
| 20163600 | 20063022 | 1.64 | 78.3 | Adjuvant (A) | 2019-01-28 | 2019-01-31 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 100728497 |
| 20163602 | 20063023 | 1.48 | 62.9 | Neo-adjuvant (N) | 2019-03-24 | 2019-03-29 | ECX | N | N | ECX | 100073507 |
| 20163615 | 20063024 | 1.63 | 78.9 | Palliative (P) | 2019-02-04 | 2019-02-21 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101319339 |
| 20163616 | 20063025 | 1.51 | 70 | Curative (C) | 2019-09-02 | 2019-09-10 | CAPECITABINE + GEMCITABINE | N | null | CAPECITABINE + GEMCITABINE | 100303575 |
| 20163620 | 20063026 | 1.71 | 69.6 | Palliative (P) | 2018-05-11 | 2018-05-28 | Gemcitabine + Capecitabine | N | N | CAPECITABINE + GEMCITABINE | 101202059 |
| 20163626 | 20063027 | 1.7 | 58.6 | Neo-adjuvant (N) | 2019-01-27 | 2019-02-02 | ECX | 2 | N | ECX | 101238962 |
| 20163627 | 20063028 | 1.74 | 58.8 | Palliative (P) | 2018-01-05 | 2018-01-19 | ECX | 02 | N | ECX | 100114872 |